AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

STRATEC SE

Declaration of Voting Results & Voting Rights Announcements Feb 3, 2010

416_dva_2010-02-03_1a05185f-e08c-49e9-9d8a-29b84691a6a5.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

News Details

Voting Rights Announcements | 3 February 2010 14:16

STRATEC Biomedical Systems AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical Systems AG / Release of an announcement according to Article 21, Section 1 of the WpHG [the German Securities Trading Act] (share)

03.02.2010

Dissemination of a Voting Rights announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


Threadneedle Investment Funds ICVC, London, UK, has notified us pursuant to
§ 21 sec. 1 WpHG on 2 February 2010, that on 28 January 2010 the share of
voting rights in STRATEC Biomedical Systems AG, Birkenfeld, Germany, ISIN:
DE0007289001, went above the threshold of 5% and that the percentage of
voting rights on that day amounted to 5.175% (592,302 shares). These voting
rights are directly held by Threadneedle Investment Funds ICVC.

Threadneedle Investment Services Limited, London, UK, has notified us
pursuant to § 21 sec. 1 WpHG on 2 February 2010, that on 28 January 2010
the share of voting rights in STRATEC Biomedical Systems AG, Birkenfeld,
Germany, ISIN: DE0007289001, went above the threshold of 5% and that the
percentage of voting rights on that day amounted to 5.175% (592,302
shares). Pursuant to § 22 para. 1 sent. 1 No. 6 WpHG, these voting rights
are in their entirety attributable to Threadneedle Investment Services
Limited, London, UK. These voting rights are directly held by Threadneedle
Investment Funds ICVC.

Threadneedle Asset Management Limited, London, UK, has notified us pursuant
to § 21 sec. 1 WpHG on 2 February 2010, that on 28 January 2010 the share
of voting rights in STRATEC Biomedical Systems AG, Birkenfeld, Germany,
ISIN: DE0007289001, went above the threshold of 5% and that the percentage
of voting rights on that day amounted to 5.571% (637,670 shares). These
voting rights are in their entirety attributable to Threadneedle Asset
Management Limited, London, UK. pursuant to § 22 para. 1 sent. 1 No. 6
WpHG. These voting rights are directly held by Threadneedle Investment
Funds ICVC and other Funds.

03.02.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP.
Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English
Company: STRATEC Biomedical Systems AG
Gewerbestraße 37
75217 Birkenfeld
Deutschland
Internet: www.stratec-biomedical.de

End of News DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.